Top & Current
Thu, October 5, 2023
[ Thu, Oct 05th 2023
] - WOPRAI
Mon, August 14, 2023
[ Mon, Aug 14th 2023
] - WOPRAI
Wed, July 26, 2023
[ Wed, Jul 26th 2023
] - WOPRAI
Wed, April 12, 2023
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
Fri, August 5, 2022
[ Fri, Aug 05th 2022
] - WOPRAI
Fri, May 6, 2022
[ Fri, May 06th 2022
] - WOPRAI
Fri, April 29, 2022
[ Fri, Apr 29th 2022
] - WOPRAI
Thu, February 24, 2022
[ Thu, Feb 24th 2022
] - WOPRAI
Tue, February 8, 2022
[ Tue, Feb 08th 2022
] - WOPRAI
Tue, April 20, 2021
[ Tue, Apr 20th 2021
] - WOPRAI
Tue, February 16, 2021
[ Tue, Feb 16th 2021
] - WOPRAI
Mon, June 15, 2020
[ Mon, Jun 15th 2020
] - WOPRAI
Jeff Garro Reiterated (ACCD) at Buy and Held Target at $18 on, Oct 5th, 2023
Jeff Garro of Stephens & Co., Reiterated "Accolade, Inc." (ACCD) at Buy and Held Target at $18 on, Oct 5th, 2023.
Jeff has made no other calls on ACCD in the last 4 months.
There are 5 other peers that have a rating on ACCD. Out of the 5 peers that are also analyzing ACCD, 3 agree with Jeff's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ricky Goldwasser of "Morgan Stanley" Reiterated at Hold and Held Target at $14 on, Monday, July 3rd, 2023
- Stan Berenshteyn of "Wells Fargo" Maintained at Hold with Increased Target to $14 on, Friday, June 30th, 2023
- Jonathan Yong of "Credit Suisse" Maintained at Hold with Increased Target to $15 on, Friday, June 30th, 2023
These are the ratings of the 2 analyists that currently disagree with Jeff
- Ryan MacDonald of "Needham" Reiterated at Strong Buy and Held Target at $17 on, Monday, October 2nd, 2023
- David Grossman of "Stifel" Maintained at Strong Buy with Increased Target to $17 on, Friday, June 30th, 2023